Global Viral Vectors & Plasmid DNA Manufacturing Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
Segmented by Vector Type;
Adenovirus, Retrovirus, Plasmid DNA, AAV, Lentivirus and Others.Segmented by Workflow;
Upstream Processing - Vector Amplification & Expansion and Vector Recovery/Harvesting, Downstream Processing - Purification and Fill-finish.Segmented by Application;
Antisense & RNAi, Gene Therapy, Cell Therapy and Vaccinology.Segmented by End Use;
Pharmaceutical and Biopharmaceutical Companies and Research Institutes.Segmented by Disease Type;
Cancer, Genetic Disorders, Infectious Diseases and Others.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Viral Vectors & Plasmid DNA Manufacturing Market (USD Million), 2020 - 2030
# | Global |
---|---|
2020 | 80.3 |
2021 | 95.3 |
2022 | 97.6 |
2023 | 102.9 |
2024 | 107.0 |
2025 | 119.9 |
2026 | 127.3 |
2027 | 145.2 |
2028 | 154.0 |
2029 | 155.7 |
2030 | 184.1 |
In the year 2023, the Global Viral Vectors & Plasmid DNA Manufacturing Market was valued at USD 2,057.42 million. The size of this market is expected to increase to USD 7,415.21 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 20.1%.
Global Viral Vectors & Plasmid DNA Manufacturing Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Viral Vectors & Plasmid DNA Manufacturing Market |
Study Period | 2020 - 2030 |
Base Year (for Viral Vectors & Plasmid DNA Manufacturing Market Size Estimates) | 2023 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Viral Vectors & Plasmid DNA Manufacturing Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Viral Vectors & Plasmid DNA Manufacturing Market Analysis
In this report, the Global Viral Vectors & Plasmid DNA Manufacturing Market has been segmented by Vector Type, Workflow, Application, End Use, Disease Type and Geography.
Global Viral Vectors & Plasmid DNA Manufacturing Market, Segmentation by Vector Type
The Global Viral Vectors & Plasmid DNA Manufacturing Market has been segmented by Vector Type into Adenovirus, Retrovirus, Plasmid DNA, AAV, Lentivirus and Others. The complete Global Viral Vectors & Plasmid DNA Manufacturing Market segmentation by Vector Type can be seen below:
- Global Viral Vectors & Plasmid DNA Manufacturing Market, By Vector Type
- Adenovirus
- Retrovirus
- Plasmid DNA
- AAV
- Lentivirus
- Others
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Vector Types mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Vector Type is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Viral Vectors & Plasmid DNA Manufacturing Market, by Vector Type (USD Million), 2020 - 2030
# | Adenovirus | Retrovirus | Plasmid DNA | AAV | Lentivirus | Others |
---|---|---|---|---|---|---|
2020 | 99.2 | 77.4 | 93.5 | 83.7 | 71.0 | 99.0 |
2021 | 109.3 | 88.5 | 111.3 | 97.4 | 74.0 | 99.5 |
2022 | 117.2 | 103.3 | 119.5 | 115.6 | 81.4 | 114.7 |
2023 | 122.6 | 109.2 | 127.8 | 131.2 | 96.3 | 123.9 |
2024 | 134.6 | 129.1 | 133.7 | 154.2 | 107.3 | 124.8 |
2025 | 143.8 | 145.8 | 135.6 | 172.4 | 117.9 | 131.0 |
2026 | 167.7 | 153.6 | 153.1 | 191.3 | 127.4 | 143.1 |
2027 | 200.4 | 162.2 | 165.9 | 199.1 | 128.1 | 149.8 |
2028 | 222.1 | 182.4 | 196.6 | 211.3 | 147.2 | 150.7 |
2029 | 246.5 | 210.1 | 231.6 | 216.4 | 154.1 | 164.9 |
2030 | 276.2 | 225.7 | 269.2 | 242.2 | 173.5 | 193.8 |
Global Viral Vectors & Plasmid DNA Manufacturing Market, Segmentation by Workflow
The Global Viral Vectors & Plasmid DNA Manufacturing Market has been segmented by Workflow into Upstream Processing and Downstream Processing. The complete Global Viral Vectors & Plasmid DNA Manufacturing Market segmentation by Workflow can be seen below:
- Global Viral Vectors & Plasmid DNA Manufacturing Market, By Workflow
- Upstream Processing
- Vector Amplification & Expansion
- Vector Recovery/Harvesting
- Downstream Processing
- Purification
- Fill-finish
- Upstream Processing
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Workflows mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Workflow is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Viral Vectors & Plasmid DNA Manufacturing Market, by Workflow (USD Million), 2020 - 2030
# | Upstream Processing | Downstream Processing |
---|---|---|
2020 | 56.2 | 96.6 |
2021 | 64.7 | 112.8 |
2022 | 70.2 | 126.4 |
2023 | 78.0 | 150.7 |
2024 | 78.3 | 170.4 |
2025 | 90.3 | 178.3 |
2026 | 98.5 | 201.7 |
2027 | 109.8 | 204.9 |
2028 | 130.3 | 227.5 |
2029 | 156.2 | 256.9 |
2030 | 168.2 | 294.0 |
Global Viral Vectors & Plasmid DNA Manufacturing Market, Segmentation by Application
The Global Viral Vectors & Plasmid DNA Manufacturing Market has been segmented by Application into Antisense & RNAi, Gene Therapy, Cell Therapy and Vaccinology. The complete Global Viral Vectors & Plasmid DNA Manufacturing Market segmentation by Application can be seen below:
- Global Viral Vectors & Plasmid DNA Manufacturing Market, By Application
- Antisense & RNAi
- Gene Therapy
- Cell Therapy
- Vaccinology
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Applications mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Application is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Viral Vectors & Plasmid DNA Manufacturing Market, by Application (USD Million), 2020 - 2030
# | Antisense & RNAi | Gene Therapy | Cell Therapy | Vaccinology |
---|---|---|---|---|
2020 | 89.1 | 63.7 | 100.2 | 52.8 |
2021 | 97.3 | 64.8 | 104.9 | 54.4 |
2022 | 115.9 | 73.0 | 121.6 | 60.5 |
2023 | 122.6 | 79.0 | 122.3 | 68.5 |
2024 | 132.5 | 90.4 | 142.2 | 78.5 |
2025 | 148.2 | 103.2 | 167.8 | 85.5 |
2026 | 159.3 | 111.1 | 177.4 | 90.8 |
2027 | 159.3 | 129.9 | 197.6 | 93.5 |
2028 | 166.3 | 149.2 | 226.5 | 112.1 |
2029 | 188.9 | 149.4 | 236.4 | 128.5 |
2030 | 196.2 | 164.2 | 257.9 | 147.0 |
Global Viral Vectors & Plasmid DNA Manufacturing Market, Segmentation by End Use
The Global Viral Vectors & Plasmid DNA Manufacturing Market has been segmented by End Use into Pharmaceutical and Biopharmaceutical Companies and Research Institutes. The complete Global Viral Vectors & Plasmid DNA Manufacturing Market segmentation by End Use can be seen below:
- Global Viral Vectors & Plasmid DNA Manufacturing Market, By End Use
- Pharmaceutical and Biopharmaceutical Companies
- Research Institutes
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the End Uses mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by End Use is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Viral Vectors & Plasmid DNA Manufacturing Market, by End Use (USD Million), 2020 - 2030
# | Pharmaceutical and Biopharmaceutical Companies | Research Institutes |
---|---|---|
2020 | 79.5 | 76.5 |
2021 | 79.9 | 87.5 |
2022 | 86.0 | 96.3 |
2023 | 96.1 | 112.1 |
2024 | 113.8 | 121.3 |
2025 | 134.9 | 133.2 |
2026 | 148.9 | 138.1 |
2027 | 169.9 | 138.5 |
2028 | 180.4 | 158.7 |
2029 | 205.9 | 161.7 |
2030 | 209.3 | 185.8 |
Global Viral Vectors & Plasmid DNA Manufacturing Market, Segmentation by Disease Type
The Global Viral Vectors & Plasmid DNA Manufacturing Market has been segmented by Disease Type into Cancer, Genetic Disorders, Infectious Diseases and Others. The complete Global Viral Vectors & Plasmid DNA Manufacturing Market segmentation by Disease Type can be seen below:
- Global Viral Vectors & Plasmid DNA Manufacturing Market, By Disease Type
- Cancer
- Genetic Disorders
- Infectious Diseases
- Others
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Disease Types mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Disease Type is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Viral Vectors & Plasmid DNA Manufacturing Market, by Disease Type (USD Million), 2020 - 2030
# | Cancer | Genetic Disorders | Infectious Diseases | Others |
---|---|---|---|---|
2020 | 80.8 | 55.9 | 63.8 | 69.3 |
2021 | 80.9 | 63.2 | 70.6 | 77.2 |
2022 | 90.3 | 75.4 | 78.3 | 86.3 |
2023 | 94.5 | 88.6 | 88.6 | 98.9 |
2024 | 98.7 | 89.5 | 100.8 | 104.1 |
2025 | 101.0 | 103.1 | 107.1 | 107.5 |
2026 | 119.1 | 120.7 | 124.3 | 110.6 |
2027 | 133.5 | 137.2 | 141.9 | 112.1 |
2028 | 138.2 | 154.0 | 158.4 | 113.2 |
2029 | 141.0 | 163.7 | 171.9 | 131.2 |
2030 | 159.5 | 163.7 | 183.7 | 134.0 |
Global Viral Vectors & Plasmid DNA Manufacturing Market, Segmentation by Geography
In this report, the Global Viral Vectors & Plasmid DNA Manufacturing Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Viral Vectors & Plasmid DNA Manufacturing Market Share (%), by Geographical Region, 2023
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Viral Vectors & Plasmid DNA Manufacturing Market in all the Regions and Countries (specified above) for historic (2020 - 2023) and forecast (2024 - 2030) Periods with 2023 considered as the base year.
This report also provides an analysis of why the market size of Viral Vectors & Plasmid DNA Manufacturing in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Viral Vectors & Plasmid DNA Manufacturing Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The growth of the Global Viral Vectors & Plasmid DNA Manufacturing Market is driven by; Robust pipeline for gene therapies and viral vector vaccines, Technological advancements in manufacturing vectors and Highly competitive market and various strategies undertaken by market entities.
- While the growth of Global Viral Vectors & Plasmid DNA Manufacturing Market is currently hindered by; Regulatory.
- Global Viral Vectors & Plasmid DNA Manufacturing Market has good growth potential in the future due to the new market opportunities that are being created. The opportunities in this market include; Facility expansion for cell and gene therapies.
- Robust pipeline for gene therapies and viral vector vaccines.
- Technological advancements in manufacturing vectors.
- Highly competitive market and various strategies undertaken by market entities.
- Regulatory, scientific, and ethical challenges associated with gene therapy.
- Facility expansion for cell and gene therapies.
Market Opportunity Map
This report provides market opportunity map for Viral Vectors & Plasmid DNA Manufacturing Market. The opportunity map (by market segments; Vector Type, Workflow, Application, End Use and Disease Type) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Viral Vectors & Plasmid DNA Manufacturing Market, Opportunity Map, By Region (2020 - 2030)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Viral Vectors & Plasmid DNA Manufacturing Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Viral Vectors & Plasmid DNA Manufacturing Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Viral Vectors & Plasmid DNA Manufacturing Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value. Production of viral vectors Viral vector gene therapy can introduce therapeutic payloads into human cells to treat previously incurable diseases by exploiting the way viruses hijack cell machinery to express viral genes. Virocell biologics is a contract development and manufacturing organization (cdmo) that produces viral vectors and gene-modified cells to allow novel cell and gene therapies to enter clinical trials. Transfection, sequencing, screening clones, restriction digestion, cloning, and pcr are all downstream applications for plasmid DNA. A plasmid vector expressing the desired protein under the control of an appropriate promoter is injected beneath the skin or muscle. Mayonnaise is an oil-in-water emulsion with more than 74% vegetable oil. Ossotide has been shown to promote osteoblast differentiation as an effective bone formation compound preparation. The Indian plywood industry, baby food industry, tobacco industry, sanitary ware industry, and ice cream industry are all growing. Understanding the facial growth trend is critical in orthodontic treatment. World cashew All young patients undergoing a preorthodontic guidance program should have a lateral headfilm taken to predict the best time to begin any mechanical procedures and to determine the type of facial growth trend. The petrochemicals industry has a higher value addition than most other industry sectors. It features products that are heavily promoted on the eponymous television channel and in commercials.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Viral Vectors & Plasmid DNA Manufacturing Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Viral Vectors & Plasmid DNA Manufacturing Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Viral Vectors & Plasmid DNA Manufacturing Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Viral Vectors & Plasmid DNA Manufacturing Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Viral Vectors & Plasmid DNA Manufacturing Market include, Merck KGaA, Lonza, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Cobra Biologics Ltd., Brammer Bio, Waisman Biomanufacturing, Genezen and YPOSKESI.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Global Viral Vectors & Plasmid DNA Manufacturing Market
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Vector Type
- Market Snapshot, By Workflow
- Market Snapshot, By Application
- Market Snapshot, By End Use
- Market Snapshot, By Disease Type
- Market Snapshot, By Region
- Market Opportunity Map
- Global Viral Vectors & Plasmid DNA Manufacturing Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Robust pipeline for gene therapies and viral vector vaccines
- Technological advancements in manufacturing vectors
- Highly competitive market and various strategies undertaken by market entities
- Restraints
- Regulatory, scientific, and ethical challenges associated with gene therapy
- Opportunities
- Facility expansion for cell and gene therapies
- Drivers
- Reimbursement Scenario
- Mergers & Acquisitions, Collaborations & Partnerships, Agreements
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Viral Vectors & Plasmid DNA Manufacturing Market, By Vector Type, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Adenovirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Retrovirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Plasmid DNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- AAV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Lentivirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Adenovirus
- Global Viral Vectors & Plasmid DNA Manufacturing Market, By Workflow, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Upstream Processing
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Vector Amplification & Expansion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Vector Recovery/Harvesting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Vector Amplification & Expansion
- Downstream Processing
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Purification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Fill-finish
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Purification
- Upstream Processing
- Global Viral Vectors & Plasmid DNA Manufacturing Market, By Application, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Antisense & RNAi
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Vaccinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Antisense & RNAi
- Global Viral Vectors & Plasmid DNA Manufacturing Market, By End Use, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Pharmaceutical and Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Pharmaceutical and Biopharmaceutical Companies
- Global Viral Vectors & Plasmid DNA Manufacturing Market, By Disease Type, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Genetic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Cancer
- Global Viral Vectors & Plasmid DNA Manufacturing Market, By Geography, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Japan
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Brazil
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vector Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Workflow, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- GCC
- North America
- Global Viral Vectors & Plasmid DNA Manufacturing Market, By Vector Type, 2022 - 2032 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Merck KGaA
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Lonza
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Cobra Biologics Ltd.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Brammer Bio
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Waisman Biomanufacturing
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Genezen
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- YPOSKESI
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Merck KGaA
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2023, the Global Virtual Clinical Trials Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Virtual Companion Care Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Vitamin D Deficiency Treatment Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Vitrification Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%